Cardiotech International, Inc.

Woburn, MA 01801

SBIR Award Summary

Total Number of Awards 12
Total Value of Awards $500K
First Award Date 09/25/96
Most Recent Award Date 09/01/01

Key Personnel

Last Name Name Awards Contact
Szycher Michael Szycher 12

12 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02

Infection of polymeric biomaterials is a major problem. In phase I, the antibiotic ciprofloxacin (Cipro) was applied to an ionic polyurethane (cPU) using textile dyeing technology, and the application parameters were optimized. No exogenous binding agents were involved. This "dyed"-cPU demonstrated slow release of Cipro with sustained antimicr...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/04/00 - 08/31/01

Infection of polymeric biomaterials is a major problem. In phase I, the antibiotic ciprofloxacin (Cipro) was applied to an ionic polyurethane (cPU) using textile dyeing technology, and the application parameters were optimized. No exogenous binding agents were involved. This "dyed"-cPU demonstrated slow release of Cipro with sustained antimicr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/23/99 - 03/22/00

Atherosclerotic cardiovascular disease is the number one cause of morbidity and mortality in the western world. This may lead to arterial stenosis. When this occurs, the consequences range from gangrene, to stroke to myocardial infarction. At the moment, autologous saphenous veins are the treatment modality of choice in low blow flow vessels suc...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/99 - 03/14/00

Atherosclerotic cardiovascular disease is the number one cause of morbidity and mortality in the western world. This may lead to arterial stenosis. When this occurs, the consequences range from gangrene, to stroke to myocardial infarction. At the moment, autologous saphenous veins are the treatment modality of choice in low blow flow vessels suc...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 07/30/99 - 06/30/00

DESCRIPTION (Adapted from applicant's abstract): Three medical-grade polyurethane families have attained commercial significance: (1) an aromatic polyurethaneurea (BIOMER, MITRATHANE); (2) aliphatic polyetherurethanes (TECOFLEX, TEXIN DP7); (3) aromatic, polyetherurethanes (PEL...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/99 - 04/30/00

DESCRIPTION: (adapted from the applicant's abstract). Biomaterial infection is a topic of concern with considerable human and economic costs. The investigators seek to develop infection -- resistant polyurethanes using techniques from polymer chemistry, textile science and biomedical research. Their university collaborators' have generated infec...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/98 - 07/31/99

The overall goal of this project is to develop a thromboresistant, small diameter prosthetic arterial graft for use in the clinical setting. Currently, there are no acceptable prostheses which can be utilized for vascular repair or replacement in situations which require a conduit with ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/98 - 06/30/99

DESCRIPTION (Adapted from applicant's abstract): Three medical-grade polyurethane families have attained commercial significance: (1) an aromatic polyurethaneurea (BIOMER, MITRATHANE); (2) aliphatic polyetherurethanes (TECOFLEX, TEXIN DP7); (3) aromatic, polyetherurethanes (PEL...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/97 - 07/30/98

The overall goal of this project is to develop a thromboresistant, small diameter prosthetic arterial graft for use in the clinical setting. Currently, there are no acceptable prostheses which can be utilized for vascular repair or replacement in situations which require a conduit with ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/97 - 11/30/99

Atherosclerotic cardiovascular disease is the number one cause of morbidity and mortality in the western world. This may lead to arterial stenosis which may ultimately lead to occlusion. When this occurs, the consequences range from gangrene, to stroke or to myocardial infarction. ...

Load More